Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood Glucose (Q65473413)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood Glucose |
clinical trial |
Statements
PRADO (English)
0 references
A Pan-European Randomized, Parallel Group, Two-arm Placebo-controlled, Double-blind Multicenter Study of Rimonabant 20mg Once Daily in the Treatment of Abdominally Obese Patients With Impaired Fasting Blood Glucose With or Without Other Comorbidities (English)
0 references
December 2006
0 references
February 2009
0 references
2,666
0 references
18 year
0 references
75 year
0 references